Parkman Healthcare Partners’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.96M | Buy |
220,387
+54,109
| +33% | +$1.46M | 0.68% | 55 |
|
|
2025
Q1 | $4.93M | Buy |
166,278
+65,977
| +66% | +$1.96M | 0.58% | 50 |
|
|
2024
Q4 | $3.97M | Sell |
100,301
-28,959
| -22% | -$1.15M | 0.53% | 50 |
|
|
2024
Q3 | $4.4M | Sell |
129,260
-80,215
| -38% | -$2.73M | 0.56% | 58 |
|
|
2024
Q2 | $4.54M | Sell |
209,475
-44,617
| -18% | -$967K | 0.61% | 57 |
|
|
2024
Q1 | $5.63M | Buy |
254,092
+16,776
| +7% | +$372K | 0.69% | 49 |
|
|
2023
Q4 | $6.53M | Buy |
237,316
+11,444
| +5% | +$315K | 0.92% | 36 |
|
|
2023
Q3 | $5.04M | Buy |
225,872
+13,912
| +7% | +$311K | 0.92% | 36 |
|
|
2023
Q2 | $5.4M | Buy |
211,960
+93,338
| +79% | +$2.38M | 0.94% | 33 |
|
|
2023
Q1 | $2.65M | Buy |
118,622
+896
| +0.8% | +$20K | 0.58% | 51 |
|
|
2022
Q4 | $2.79M | Buy |
117,726
+56,843
| +93% | +$1.35M | 0.74% | 50 |
|
|
2022
Q3 | $1.01M | Sell |
60,883
-13,083
| -18% | -$217K | 0.29% | 70 |
|
|
2022
Q2 | $1.47M | Buy |
73,966
+13,315
| +22% | +$265K | 0.54% | 50 |
|
|
2022
Q1 | $1.67M | Sell |
60,651
-1,613
| -3% | -$44.5K | 0.49% | 51 |
|
|
2021
Q4 | $2.57M | Buy |
62,264
+17,264
| +38% | +$711K | 0.57% | 45 |
|
|
2021
Q3 | $2.09M | Buy |
+45,000
| New | +$2.09M | 0.53% | 52 |
|